The goal of this virtual discussion is to explore practical solutions for keeping seniors safe. The ideas are drawn from real life experiences noting how COVID-19 impacted seniors, their loved ones as well as healthcare workers and leaders.
The focus of the discussion is on identifying safety risks together with practical solutions for seniors who live at home, in residences and long-term care facilities.
Failure to Rescue is ranked #2 in healthcare claims in Canada (HIROC, 2017) Additionally, Health Standards Organization (HSO) recently updated the critical care and inpatient services standards sets to include requirements supporting the recognition and response to clinical deterioration.
Full details: https://goo.gl/cfTUrm
2021-2022 NTTAP Webinar: Fundamentals of Comprehensive CareCHC Connecticut
Join us as we discuss the core concepts of team-based care and introduce elements of team-based care that builds upon these basics to support your teams in advancing their capability to provide satisfying and effective care to complex patient populations. .
We will be joined by Margaret Flinter, Senior Vice President/Clinical Director for Community Health Center, Inc., and both Thomas Bodenheimer, MD, Physician and Founding Director, and Rachel Willard Grace, Director, from the Center for Excellence in Primary Care.
Support of HIV Prevention initiatives and programmes at Karen Hospital are entrenched in the treatment
Outreach programmes to corporate, companies the universities around Karen area
Target: those who have not been tested for HIV/AIDS to carry out tests and know their statuses in order to take control of their lives
Success: More enquiries and actual use of the contraceptives both duo method and dual protection.
This interactive webinar is part of the world tour series designed by the World Health Organization's Patients for Patient Safety (PFPS) Global Network and hosted by Patients for Patient Safety Canada, the patient-led program of the Canadian Patient Safety Institute, a WHO Collaborating Centre on Patient Safety and Patient Engagement.
In Search of What Works: Re-Defining Post Acute Partnerships to Reduce Readmissions, Using the Integrated Chronic Disease Care at Home Model
Ms. Ann Rodriguez-McConnell, R.N.
Mano y Corazón Binational Conference of Multicultural Health Care Solutions, El Paso, Texas, September 27-28, 2013
The goal of this virtual discussion is to explore practical solutions for keeping seniors safe. The ideas are drawn from real life experiences noting how COVID-19 impacted seniors, their loved ones as well as healthcare workers and leaders.
The focus of the discussion is on identifying safety risks together with practical solutions for seniors who live at home, in residences and long-term care facilities.
Failure to Rescue is ranked #2 in healthcare claims in Canada (HIROC, 2017) Additionally, Health Standards Organization (HSO) recently updated the critical care and inpatient services standards sets to include requirements supporting the recognition and response to clinical deterioration.
Full details: https://goo.gl/cfTUrm
2021-2022 NTTAP Webinar: Fundamentals of Comprehensive CareCHC Connecticut
Join us as we discuss the core concepts of team-based care and introduce elements of team-based care that builds upon these basics to support your teams in advancing their capability to provide satisfying and effective care to complex patient populations. .
We will be joined by Margaret Flinter, Senior Vice President/Clinical Director for Community Health Center, Inc., and both Thomas Bodenheimer, MD, Physician and Founding Director, and Rachel Willard Grace, Director, from the Center for Excellence in Primary Care.
Support of HIV Prevention initiatives and programmes at Karen Hospital are entrenched in the treatment
Outreach programmes to corporate, companies the universities around Karen area
Target: those who have not been tested for HIV/AIDS to carry out tests and know their statuses in order to take control of their lives
Success: More enquiries and actual use of the contraceptives both duo method and dual protection.
This interactive webinar is part of the world tour series designed by the World Health Organization's Patients for Patient Safety (PFPS) Global Network and hosted by Patients for Patient Safety Canada, the patient-led program of the Canadian Patient Safety Institute, a WHO Collaborating Centre on Patient Safety and Patient Engagement.
In Search of What Works: Re-Defining Post Acute Partnerships to Reduce Readmissions, Using the Integrated Chronic Disease Care at Home Model
Ms. Ann Rodriguez-McConnell, R.N.
Mano y Corazón Binational Conference of Multicultural Health Care Solutions, El Paso, Texas, September 27-28, 2013
2.5 Partnership working - Anne Forletta, Katherine HewittNHS England
Partnership working. Building partnerships with acute hospitals, voluntary and community services. Featuring examples from Birmingham and Coventry. Anne Forletta, My Healthcare Birmingham; Katherine Hewitt, Gateway Family Services, Birmingham.
Please share this slideshow with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
● Discussion of the CADTH Symposium
● Recommendations for HTA improvements in Canada
● Audience Q&A
View the video: https://youtu.be/AJCOemf2r6Y
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
Learn how Hahnemann University Hospital reduced readmissions at the Center for Advanced Heart Failure Care by over 20%. This is a follow up to our Fall 2014 webinar with more data and outcomes to reveal. During this discussion, you’ll learn the positive impact a Readmissions Reduction program can have for a hospital including financial, care delivery, and care team collaboration improvements.
Va Health Literacy Research Presentationguest169e62f
What is the Impact of Low VA Patient Literacy on VA Diabetes Patient Educational Initiatives?
Department of Veterans Affairs Medical Center, North Chicago, IL USA
VA Diabetes Education Research Study 2008David Donohue
What is the Impact of Low VA Patient Literacy on VA Diabetes Patient Educational Initiatives?
Department of Veterans Affairs Medical Center, North Chicago, IL USA
mHealth Israel_Incorporating the Patient Voice into Clinical Delivery Models ...Levi Shapiro
Incorporating the Patient Voice into Clinical Delivery Models for Person-Centered Care, presentation by Alan Balch, CEO, National Patient Advocate Foundation.
Sussex Partnership NHS Foundation Trust - one of the partners working with NHS Improving Quality on the Winterbourne Medicines Programme
Presentation from the Winterbourne Medicines Programme Launch held in London on 10 September 2014
Ensuring safe, appropriate and optimised use of medication for people with learning disabilities who demonstrate behaviour that can challenge
Acute hospitals end of life care best practiceNHSRobBenson
Delivering reliable best practice in an acute hospital setting for patients whose recovery is uncertain. Including details of the AMBER care bundle. Presentation from Anita Hayes and colleagues from England's National End of Life Care Programme as part of the Department of Health's QIPP end of life care workstream seminar series at Healthcare Innovation Expo 2011
Similar to RDD 2020 Day 1: AM Sandra Anderson (20)
On this webinar, we’ll hear from experts on the issue and invite an open conversation with stakeholders. We need discussion, shared questions and answers and a review of case studies, which is why we are hosting this session.
Panelist:
Neil Palmer, Principal Consultant, WN Palmer & Co. and former PMPRB staff
Michael Dietrich, Executive Director, Policy, Innovative Medicines Canada
Laurene Redding, Global Head, Strategic Pricing (ex-China), BeiGene
Durhane Wong-Rieger, President & CEO, CORD
Moderator: Bill Dempster, CEO, 3Sixty Public Affairs
CORD Rare Drug Conference: June 8-9, 2022
Registries and Real-World Data
INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty,
Monica Lamoureux, John Adams, Kim Angel
CORD Rare Drug Conference: June 8-9, 2022
Registries and Real-World Data
INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty,
Monica Lamoureux, John Adams, Kim Angel Opportunities and Challenges for Data Management
CORD Rare Drug Conference June 8-9, 2022
Global, International, and National Rare Disease Networks
Rare Disease Research Network and National Children’s Hospital - Marshall
Summar, Rare Disease Institute
CORD Rare Drug Conference: June 8-9, 2022
Global, International, and National Rare Disease Networks
WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
CORD Rare Drug Conference: June 8-9, 2022
Global, International, and National Rare Disease Networks
Canadian Network of Rare Disease Centres of Excellence - Paula Robeson, Children’s Healthcare Canada
CORD Rare Drug Conference: June 8 - 9, 2022
The Ottawa Pediatric Bone Health Research Group and The Canadian Consortium for Children’s Bone Health/Canadian Alliance for Rare Disorders of the Skeleton - Leanne Ward, CHEO
More from Canadian Organization for Rare Disorders (20)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
1. Support Programs for Rare
Disease Patients and Families
CORD Rare Disease Day Conference 2020
Sandra Anderson, SVP Commercialization and
Strategy
Innomar Strategies
2. Navigating a complex ecosystem
EAP
Counselor
PhysicianPatient
Private
Payers
Public
Payers
Physician
Nurse
EAP
Counselor
Pharmacist
Social
Worker
Advocacy
Groups
Social
Assistance
Worker
Disability
worker
Dietitian
Physio
Mental
Health
3/12/20 CONFIDENTIAL2
3. Challenges in maintaining access to therapy
Understanding complex
insurance policies and prior
authorization requirements
High out-of-pocket expense
associated with premiums
or co-insurance (co-pay)
Clinical issues that threaten
adherence to prescribed
dosing intervals
(e.g. injection support, side
effects, prescription access)
Changes in personal
circumstances and/or
site of care
(e.g. support between appts,
geographic relocation, appt
accessibility)
3/12/20 CONFIDENTIAL4
4. The patient journey in rare disease
Enrolment in PSP
INITIATINGTREATMENT
ACCESSTOTHERAPYONGOINGCARE
Patient • Physician completes enrolment
and fax/email into PSP
First Contact
• Nurse Case Manager contacts patient/caregiver
• Obtains detailed patient history
Submission of Special
Authorization-Public/Private
• Details of medical history
• Details of applicable diagnostic testing results
and lab testing
Financial assistance?
High financial burden
• Co-pay, deductibles, lifetime maximums
• Low percentage covered
• Benefit not covered; Therapy not on formulary
Is an appeal required?
Additional diagnostic or lab testing?
Additional clinical information required?
Employer escalation?
Nursing & Clinic Support
Pharmacy
Services
• Injection or infusion services
• Assessment and education
Compliance
& Insights
Holistic Services
• Physiotherapy; Mental Health
• Dietician
5. Customized patient support programs
Nurse Case Manager – One point of contact to deliver quality care at every touch-point
Update on
Patient Progress
Enrolment
Reimbursement
Infusion/Injection
Scheduled
Specialty
Pharmacy
Infusion/
Injection
Patient Experience
Innomar
Nurse Case Manager
Clinic chosen, fax to physician,
pre-infusion checklist, reminder
call, drug order
NCM assigned, patient contacted
Case Manager confirms
coverage with the patient and
sets up financial assistance
Deferral of copay, drug order,
warehouse sends drug to
pharmacy, drug delivered to Clinic
Nurse confirms drug is onsite,
pre-infusion assessment by
nurse, infusion
6. Advocacy groups
3/12/20 CONFIDENTIAL6
Education, emotional
support, network
connections, new research
Access to regional support
groups, loans/funding,
ALS clinics
Access to global patient
organizations, medical
information, news and
events
Disability tax credit,
volunteer support,
education resources,
travel cost assistance
Videos, treatment access
updates, new research,
conferences, education
resources
Mentoring, networking
programs, nutrition and
health resources
Financial support, referral
directory, discussion
groups, family conference,
education resources
Innovative research
funding, provision of
support with accessing
treatment in Canada
7. Wellspring programs
§ Evidence-based
§ Professionally led
§ Developed and piloted
through a rigorous research
and proposal process
§ Continually evaluated
§ On-line and classroom
educational courses and
social events
3/12/20 CONFIDENTIAL7
Programs designed to meet the emotional, social, practical and restorative needs of people living with cancer
Children and Family Coping Skills Educational Programs
Cancer Exercise Money Matters Workplace Programs
Nourish Expressive Arts Support Groups
8. Digital applications
3/12/20 CONFIDENTIAL8
E-digital tool kit helping
patients, caregivers
navigate the Ontario
health system
Online health records
linked to Hospital records
Online record sharing tool-
diagnostic imaging
Online record sharing tool
to download patient
diagnostic imaging results
Health Record
Management
Created by Patient to
navigate Healthcare for
patients and caregivers
9. Case study
3/12/20 CONFIDENTIAL9
SOLUTION
§ A number of different individuals came together and
quickly coordinate this patient’s care
§ Included was locating and securing an appointment
close to where her child was staying, same day drug
shipment, and ensuring that the patient had everything
necessary to have her injection safely and quickly
CHALLENGE
§ Patient living in Northern Ontario receives specialty
injections on an ongoing basis
§ Her baby becomes acutely unwell over the holidays and
requires the support of a tertiary hospital six hours away
§ Program receives urgent email from a physician asking
if his patient could receive her specialty injection in a
different location in order to stay with her ill baby
OUTCOME
§ The amount of steps, emails and conversations that
took place to make this happen was quite detailed
§ Every PSP member jumped in and without any
hesitation, and did what was necessary to help this
patient in her time of need
10. Case study
3/12/20 CONFIDENTIAL10
SOLUTION
§ Public EAP requested
§ Patient Advocacy: Lobby on behalf of patient; media
releases; Canada wide petition; add pressure to
decision makers; weekly telephone conferences with
stakeholders
CHALLENGE
§ Patient was hospitalized with multiple organ failure
§ The medication was still under review by the Province
OUTCOME
§ Provincial compassionate program obtained to start and
then successfully gained full approval from the province
§ Patient is still on therapy
11. In conclusion
§ Patients experience a lot of challenges when first diagnosed with a chronic
disease — especially a rare disease
§ There are gaps in support to patients in the Canadian system — access is
inconsistent and not connected
§ Manufacturer patient support programs and patient advocacy groups offer
meaningful support throughout the patient journey
§ Tracking patient outcomes and collecting meaningful data is critical for
reimbursement and access for patients
§ Newer digital tools can help link patients to various support as well as assist
them in navigating their own healthcare
3/12/20 CONFIDENTIAL11